The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Translation of ODC mRNA and polyamine transport are suppressed in ras-transformed CREF cells by depleting translation initiation factor 4E.
J R Graff; A De Benedetti; J W Olson; P Tamez; R A Casero; S G Zimmer (Profiled Author: Robert Casero)
Department of Microbiology and Immunology, L.P. Markey Cancer Center, University of Kentucky, Lexington 40536, USA.
Biochemical and biophysical research communications 1997;240(1):15-20.
Rapid tumor growth and metastasis require increased polyamine metabolism, which is coordinately regulated by ornithine decarboxylase (ODC) and the polyamine transporter. Both activities are stimulated by ras signalling and are dependent upon protein biosynthesis. T24ras oncogene expression in rat embryo fibroblasts (CREFT24) induces cellular transformation and malignancy, in part, by stimulating the rate-limiting translation initiation factor, eIF-4E. CREFT24 expressing antisense RNA to eIF-4E (AS4E) have markedly decreased tumor growth rates and metastatic capacity, without altered monolayer growth rates. Herein, we demonstrate that in AS4E, ODC is translationally suppressed resulting in decreased ODC activity. Additionally, exogenous polyamine uptake is suppressed in AS4E cells indicating that AS4E can neither generate nor import the polyamines necessary to support rapid tumor growth. These data provide evidence that eIF-4E is the link between ras-induced malignancy and increased polyamine metabolism and support the hypothesis that eIF-4E plays a pivotal role in mediating ras-induced malignancy.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
C A Vater; L M Bartle; C A Dionne; T D Littlewood; V S GoldmacherOncogene 1996;13(4):739-48.
T G O'Brien; D Saladik; L DiamondCancer research 1982;42(4):1233-8.
Mark R Burns; Gerard F Graminski; Reitha S Weeks; Yan Chen; Thomas G O'BrienJournal of medicinal chemistry 2009;52(7):1983-93.
Appears in this Publication
Author of this Publication